Search for: [Abstract = "een individual measurements have reached statistical significance. Body loss ratio in the placebo group was clearly slower, however after 12 weeks it also proved to be statistically significant compared to the first measurement in the placebo group \(p<0.01\). This may suggest that patients did attempt additional intervention. Despite the fact that diet was not intended as patients’ co\-intervention, it cannot be definitely excluded that patients, satisfied with initial success, did attempt some form of additional intervention such as diet or physical exercise. This constitutes a limitation of our study. Nonetheless, the tendency noticeable throughout the study indicates that fluoxetine is an efficient drug which lowers the appetite by stimulating the central nervous system. It is intriguing how some patients especially in the fluoxetine group significantly lost weight, whereas others in the same group gained weight. Perhaps it is connected with the relatively low dose of the drug \(20mg\). Other studies of the influence of fluoxetine on body mass used larger doses \(up to 80mg\). Discontinuation level of 21% mainly referred to patients from the placebo group perhaps they were discouraged by the lack of expected results. A considerably short observation period can be a limitation, the tendency regarding weight loss and decreased menopausal symptoms is significant, however the result w"]

Number of results: 1